Detected ·

Astrocyte Pharmaceuticals

$9.5M—

Astrocyte Pharmaceuticals completed a $9.5M Series B financing and advanced enrollment in its Phase 2 STARFAST trial for AST-004, a cerebroprotective treatment for concussion.

Website
—
LinkedIn
—
Amount
$9 500 000 USD
Stage
—
Event
Funding round
Detected
2026-10-01 04:03:43 UTC
Signal ID
56152c89-c24c-4143-8abc-b5999f2d403f

As the API returns it

{
  "id": "56152c89-c24c-4143-8abc-b5999f2d403f",
  "created_at": "2026-10-01T04:03:43.579649Z",
  "company_name": "Astrocyte Pharmaceuticals",
  "company_website_url": null,
  "company_linkedin_url": null,
  "event_type": "funding",
  "funding_amount": 9500000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*Astrocyte Pharmaceuticals completed a $9.5M Series B financing and advanced enrollment in its Phase 2 STARFAST trial for AST-004, a cerebroprotective treatment for concussion.*"
}

Latest rounds